More Studies Support Wegovy’s Long-Term Weight-Loss Benefits
TUESDAY, May 14, 2024 (HealthDay News) — Semaglutide — the active ingredient in the blockbuster weight-loss drugs Ozempic and Wegovy — can produce long-term weight and heart health benefits, a pair of new studies show. Researchers found that overweight and obese adults lost an average 10% of their body weightContinue Reading